Their device could restore movement in those who suffer from paralysis.
Neuralink co-founder said the company has submitted most of the paperwork for first clinical trials
Elon Musk has claimed that a wireless chip developed by his company Neuralink could start human clinical trials in six months. The world’s richest man also stated that the biotech startup is “confident” that their device could restore movement in those who suffer from paralysis.
Speaking at a “show and tell” event in the company’s headquarters in California on Wednesday, Musk showcased a brain-computer interface, which looks like a stack of several coins with hundreds of thin threads and is intended to be implanted in humans by a surgical robot.
Such a device could potentially restore full-body functionality to those who have a severed spinal cord, or bring back vision to people that had never seen, Musk claimed.